Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Clinical Lipidology|June 26, 2017
Real-world data to assess changes in low-density lipoprotein cholesterol and predicted cardiovascular risk after ezetimibe discontinuation post reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trialHarold E Bays, Mehul D Patel, Panagiotis Mavros, et al.
ERJ Open Research|January 19, 2023
The demographics, clinical characteristics and quality of life of patients with chronic cough from the Isala Cough Clinic in the NetherlandsJan Willem K van den Berg, Carl A Baxter, Mireille A Edens, et al.
Journal of the American Chemical Society|May 3, 2011
Reaction development and mechanistic study of a ruthenium catalyzed intramolecular asymmetric reductive amination en route to the dual Orexin inhibitor Suvorexant (MK-4305)Neil A Strotman, Carl A Baxter, Karel M J Brands, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 16, 2025
LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysisGabriela Vega-Hernandez, Gordon MacGregor, Andrew Wilfin, et al.
Archives of Cardiovascular Diseases|September 3, 2020
Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndromeJean Ferrières, Dominik Lautsch, Peter Bramlage, et al.
Heart Views : the Official Journal of the Gulf Heart Association|August 30, 2019
Prevalence of Lipid Abnormalities and Cholesterol Target Value Attainment in Patients with Stable and Acute Coronary Heart Disease in the United Arab EmiratesWael Al Mahmeed, Sherif Bakir, Salem A Beshyah, et al.
Organic Letters|March 11, 2015
Synthesis of bis-macrocyclic HCV protease inhibitor MK-6325 via intramolecular sp²-sp³ Suzuki-Miyaura coupling and ring closing metathesisHongmei Li, Jeremy P Scott, Cheng-yi Chen, et al.
European Journal of Preventive Cardiology|October 19, 2018
Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: Results from DYSIS II EuropeJean Ferrieres, Gaetano Maria De Ferrari, Michel P Hermans, et al.
Diabetes, Obesity & Metabolism|November 19, 2016
Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival dataSteve Bain, Eric Druyts, Chakrapani Balijepalli, et al.
European Journal of Preventive Cardiology|September 11, 2018
Low-density lipoprotein cholesterol target attainment in patients with stable or acute coronary heart disease in the Asia-Pacific region: results from the Dyslipidemia International Study IIKian-Keong Poh, Baishali Ambegaonkar, Carl A Baxter, et al.
Pageof 3